ID   CSK_HUMAN               Reviewed;         450 AA.
AC   P41240; Q2M3N2; Q6FGZ6;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 1.
DT   05-OCT-2010, entry version 127.
DE   RecName: Full=Tyrosine-protein kinase CSK;
DE            EC=2.7.10.2;
DE   AltName: Full=C-Src kinase;
DE   AltName: Full=Protein-tyrosine kinase CYL;
GN   Name=CSK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=92050797; PubMed=1945408;
RA   Partanen J., Armstrong E., Bergman M., Maekelae T.P., Hirvonen H.,
RA   Huebner K., Alitalo K.;
RT   "CYL encodes a putative cytoplasmic tyrosine kinase lacking the
RT   conserved tyrosine autophosphorylation site (Y416src).";
RL   Oncogene 6:2013-2018(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Lung;
RX   MEDLINE=92073297; PubMed=1720539; DOI=10.1073/pnas.88.23.10411;
RA   Braeuninger A., Holtrich U., Strebhardt K., Ruebsamen-Waigmann H.;
RT   "Two additional protein-tyrosine kinases expressed in human lung:
RT   fourth member of the fibroblast growth factor receptor family and an
RT   intracellular protein-tyrosine kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:10411-10415(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RX   PubMed=1371489; DOI=10.1016/0378-1119(92)90649-A;
RA   Brauninger A., Holtrich U., Strebhardt K., Rubsamen-Waigmann H.;
RT   "Isolation and characterization of a human gene that encodes a new
RT   subclass of protein tyrosine kinases.";
RL   Gene 110:205-211(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=93241739; PubMed=7683131;
RA   Braeuninger A., Karn T., Strebhardt K., Ruebsamen-Waigmann H.;
RT   "Characterization of the human CSK locus.";
RL   Oncogene 8:1365-1369(1993).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ASP-287; GLN-398 AND
RP   ARG-442.
RG   NIEHS SNPs program;
RL   Submitted (MAY-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PHOSPHORYLATION AT TYR-184 AND TYR-304, AND MUTAGENESIS OF TYR-184 AND
RP   TYR-304.
RX   MEDLINE=97220407; PubMed=9148770;
RA   Joukov V., Vihinen M., Vainikka S., Sowadski J.M., Alitalo K.,
RA   Bergman M.;
RT   "Identification of csk tyrosine phosphorylation sites and a tyrosine
RT   residue important for kinase domain structure.";
RL   Biochem. J. 322:927-935(1997).
RN   [9]
RP   INTERACTION WITH TGFB1I1.
RX   PubMed=10838081; DOI=10.1016/S0014-5793(00)01597-0;
RA   Ishino M., Aoto H., Sasaski H., Suzuki R., Sasaki T.;
RT   "Phosphorylation of Hic-5 at tyrosine 60 by CAKbeta and Fyn.";
RL   FEBS Lett. 474:179-183(2000).
RN   [10]
RP   INTERACTION WITH PAG1.
RX   MEDLINE=20253245; PubMed=10790433; DOI=10.1084/jem.191.9.1591;
RA   Brdicka T., Pavlistova D., Bruyns E., Leo A., Korinek V.,
RA   Angelisova P., Scherer J., Shevchenko A., Shevchenko A., Hilgert I.,
RA   Cerny J., Drbal K., Kuramitsu Y., Horejsi V., Schraven B.;
RT   "Phosphoprotein associated with glycosphingolipid-enriched
RT   microdomains (PAG), a novel ubiquitously expressed transmembrane
RT   adaptor protein, binds the protein tyrosine kinase csk and is involved
RT   in regulation of T cell activation.";
RL   J. Exp. Med. 191:1591-1604(2000).
RN   [11]
RP   INTERACTION WITH SIT1.
RX   PubMed=11433379;
RX   DOI=10.1002/1521-4141(200106)31:6<1825::AID-IMMU1825>3.0.CO;2-V;
RA   Pfrepper K.-I., Marie-Cardine A., Simeoni L., Kuramitsu Y., Leo A.,
RA   Spicka J., Hilgert I., Scherer J., Schraven B.;
RT   "Structural and functional dissection of the cytoplasmic domain of the
RT   transmembrane adaptor protein SIT (SHP2-interacting transmembrane
RT   adaptor protein).";
RL   Eur. J. Immunol. 31:1825-1836(2001).
RN   [12]
RP   INTERACTION WITH LIME1.
RX   PubMed=14610046; DOI=10.1084/jem.20031484;
RA   Brdickova N., Brdicka T., Angelisova P., Horvath O., Spicka J.,
RA   Hilgert I., Paces J., Simeoni L., Kliche S., Merten C., Schraven B.,
RA   Horejsi V.;
RT   "LIME: a new membrane raft-associated adaptor protein involved in CD4
RT   and CD8 coreceptor signaling.";
RL   J. Exp. Med. 198:1453-1462(2003).
RN   [13]
RP   INTERACTION WITH SRCIN1.
RX   PubMed=17525734; DOI=10.1038/sj.emboj.7601724;
RA   Di Stefano P., Damiano L., Cabodi S., Aramu S., Tordella L.,
RA   Praduroux A., Piva R., Cavallo F., Forni G., Silengo L., Tarone G.,
RA   Turco E., Defilippi P.;
RT   "p140Cap protein suppresses tumour cell properties, regulating Csk and
RT   Src kinase activity.";
RL   EMBO J. 26:2843-2855(2007).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-184, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-184, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=19534553; DOI=10.1021/pr900044c;
RA   Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,
RA   Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,
RA   Wiley H.S., Qian W.-J.;
RT   "An extensive survey of tyrosine phosphorylation revealing new sites
RT   in human mammary epithelial cells.";
RL   J. Proteome Res. 8:3852-3861(2009).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 1-71.
RX   MEDLINE=94185778; PubMed=7511113; DOI=10.1016/0014-5793(94)80244-0;
RA   Borchert T.V., Mathieu M., Zeelen J.P., Courtneidge S.A.,
RA   Wierenga R.K.;
RT   "The crystal structure of human CskSH3: structural diversity near the
RT   RT-Src and n-Src loop.";
RL   FEBS Lett. 341:79-85(1994).
RN   [18]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-45.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Specifically phosphorylates 'Tyr-504' on LCK, which acts
CC       as a negative regulatory site. Can also act on the LYN and FYN
CC       kinases.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBUNIT: Interacts with PTPN8 (By similarity). Interacts with
CC       phosphorylated SIT1, PAG1, LIME1 and TGFB1I1. Interacts with
CC       SRCIN1.
CC   -!- INTERACTION:
CC       P41241:Csk (xeno); NbExp=1; IntAct=EBI-1380630, EBI-2553183;
CC       P23467:PTPRB; NbExp=1; IntAct=EBI-1380630, EBI-1265766;
CC       P08575:PTPRC; NbExp=1; IntAct=EBI-1380630, EBI-1341;
CC       P23470:PTPRG; NbExp=1; IntAct=EBI-1380630, EBI-2258115;
CC       Q12913:PTPRJ; NbExp=1; IntAct=EBI-1380630, EBI-2264500;
CC       Q15262:PTPRK; NbExp=1; IntAct=EBI-1380630, EBI-474052;
CC       Q16827:PTPRO; NbExp=1; IntAct=EBI-1380630, EBI-723739;
CC       P23471:PTPRZ1; NbExp=1; IntAct=EBI-1380630, EBI-2263175;
CC       P00523:SRC (xeno); NbExp=3; IntAct=EBI-1380630, EBI-848039;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Cell membrane (By
CC       similarity). Note=Mainly cytoplasmic, also present in lipid rafts
CC       (By similarity).
CC   -!- TISSUE SPECIFICITY: Expressed in lung and macrophages.
CC   -!- PTM: Autophosphorylation of Tyr-304 occurs only at abnormally high
CC       CSK concentrations in vitro.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. CSK subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SH2 domain.
CC   -!- SIMILARITY: Contains 1 SH3 domain.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/csk/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X60114; CAA42713.1; -; mRNA.
DR   EMBL; X59932; CAA42556.1; -; mRNA.
DR   EMBL; X74765; CAB58562.1; -; Genomic_DNA.
DR   EMBL; CR541960; CAG46758.1; -; mRNA.
DR   EMBL; DQ075211; AAY57329.1; -; Genomic_DNA.
DR   EMBL; BC104847; AAI04848.1; -; mRNA.
DR   EMBL; BC104875; AAI04876.1; -; mRNA.
DR   EMBL; BC106073; AAI06074.1; -; mRNA.
DR   IPI; IPI00013212; -.
DR   PIR; JH0559; JH0559.
DR   RefSeq; NP_001120662.1; -.
DR   RefSeq; NP_004374.1; -.
DR   UniGene; Hs.77793; -.
DR   PDB; 1BYG; X-ray; 2.40 A; A=177-450.
DR   PDB; 1CSK; X-ray; 2.50 A; A/B/C/D=1-71.
DR   PDB; 3D7T; X-ray; 2.90 A; A=188-450.
DR   PDB; 3D7U; X-ray; 4.11 A; A/C=188-450.
DR   PDB; 3EAC; X-ray; 1.37 A; A=73-178.
DR   PDB; 3EAZ; X-ray; 1.31 A; A=73-178.
DR   PDBsum; 1BYG; -.
DR   PDBsum; 1CSK; -.
DR   PDBsum; 3D7T; -.
DR   PDBsum; 3D7U; -.
DR   PDBsum; 3EAC; -.
DR   PDBsum; 3EAZ; -.
DR   ProteinModelPortal; P41240; -.
DR   SMR; P41240; 6-450.
DR   IntAct; P41240; 34.
DR   MINT; MINT-85878; -.
DR   STRING; P41240; -.
DR   PhosphoSite; P41240; -.
DR   OGP; P41240; -.
DR   PRIDE; P41240; -.
DR   Ensembl; ENST00000220003; ENSP00000220003; ENSG00000103653.
DR   Ensembl; ENST00000439220; ENSP00000414764; ENSG00000103653.
DR   GeneID; 1445; -.
DR   KEGG; hsa:1445; -.
DR   UCSC; uc002ays.2; human.
DR   CTD; 1445; -.
DR   GeneCards; GC15P075075; -.
DR   H-InvDB; HIX0026799; -.
DR   HGNC; HGNC:2444; CSK.
DR   HPA; CAB011203; -.
DR   HPA; HPA026488; -.
DR   HPA; HPA028425; -.
DR   MIM; 124095; gene.
DR   PharmGKB; PA26946; -.
DR   eggNOG; prNOG08992; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG008761; -.
DR   InParanoid; P41240; -.
DR   OMA; EGIIPAN; -.
DR   OrthoDB; EOG91K1XW; -.
DR   PhylomeDB; P41240; -.
DR   BRENDA; 2.7.10.2; 247.
DR   Pathway_Interaction_DB; bcr_5pathway; BCR signaling pathway.
DR   Pathway_Interaction_DB; pdgfrbpathway; PDGFR-beta signaling pathway.
DR   Pathway_Interaction_DB; ptp1bpathway; Signaling events mediated by PTP1B.
DR   Pathway_Interaction_DB; tcrpathway; TCR signaling in naive CD4+ T cells.
DR   Pathway_Interaction_DB; cd8tcrpathway; TCR signaling in naive CD8+ T cells.
DR   Reactome; REACT_13552; Integrin cell surface interactions.
DR   Reactome; REACT_604; Hemostasis.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   Reactome; REACT_9417; Signaling by EGFR.
DR   NextBio; 5937; -.
DR   ArrayExpress; P41240; -.
DR   Bgee; P41240; -.
DR   CleanEx; HS_CSK; -.
DR   Genevestigator; P41240; -.
DR   GermOnline; ENSG00000103653; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kina...; IEA:EC.
DR   GO; GO:0008022; F:protein C-terminus binding; TAS:ProtInc.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR015778; Tyr_kinase_non-rcpt_Csk.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   Gene3D; G3DSA:3.30.505.10; SH2; 1.
DR   PANTHER; PTHR23256:SF264; Csk_ProtTyrKin; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF50044; SH3; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cell membrane; Complete proteome;
KW   Cytoplasm; Kinase; Membrane; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; SH2 domain; SH3 domain; Transferase;
KW   Tyrosine-protein kinase.
FT   CHAIN         1    450       Tyrosine-protein kinase CSK.
FT                                /FTId=PRO_0000088070.
FT   DOMAIN        9     70       SH3.
FT   DOMAIN       82    171       SH2.
FT   DOMAIN      195    449       Protein kinase.
FT   NP_BIND     201    209       ATP (By similarity).
FT   REGION        9     70       Interaction with PTPN8 (By similarity).
FT   ACT_SITE    314    314       Proton acceptor (By similarity).
FT   BINDING     222    222       ATP (By similarity).
FT   MOD_RES     184    184       Phosphotyrosine.
FT   MOD_RES     304    304       Phosphotyrosine; by autocatalysis.
FT   MOD_RES     416    416       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   VARIANT      45     45       P -> L.
FT                                /FTId=VAR_041678.
FT   VARIANT     287    287       G -> D (in dbSNP:rs34866753).
FT                                /FTId=VAR_025203.
FT   VARIANT     398    398       R -> Q (in dbSNP:rs34616395).
FT                                /FTId=VAR_025204.
FT   VARIANT     442    442       H -> R (in dbSNP:rs35556162).
FT                                /FTId=VAR_025205.
FT   MUTAGEN     184    184       Y->F: Abolishes phosphorylation.
FT   MUTAGEN     304    304       Y->F: Decreases activity by two-thirds
FT                                and alters conformation.
FT   STRAND       12     18
FT   STRAND       35     41
FT   STRAND       47     51
FT   STRAND       57     61
FT   STRAND       64     66
FT   HELIX       192    194
FT   STRAND      195    203
FT   STRAND      208    214
FT   STRAND      217    223
FT   HELIX       231    235
FT   HELIX       237    240
FT   STRAND      251    255
FT   STRAND      263    266
FT   HELIX       274    285
FT   HELIX       288    307
FT   HELIX       317    319
FT   STRAND      320    322
FT   STRAND      328    330
FT   TURN        350    352
FT   HELIX       355    360
FT   HELIX       365    380
FT   HELIX       392    394
FT   HELIX       395    399
FT   TURN        400    402
FT   HELIX       413    422
FT   HELIX       427    429
FT   HELIX       433    446
SQ   SEQUENCE   450 AA;  50704 MW;  431023A88C54E00C CRC64;
     MSAIQAAWPS GTECIAKYNF HGTAEQDLPF CKGDVLTIVA VTKDPNWYKA KNKVGREGII
     PANYVQKREG VKAGTKLSLM PWFHGKITRE QAERLLYPPE TGLFLVREST NYPGDYTLCV
     SCDGKVEHYR IMYHASKLSI DEEVYFENLM QLVEHYTSDA DGLCTRLIKP KVMEGTVAAQ
     DEFYRSGWAL NMKELKLLQT IGKGEFGDVM LGDYRGNKVA VKCIKNDATA QAFLAEASVM
     TQLRHSNLVQ LLGVIVEEKG GLYIVTEYMA KGSLVDYLRS RGRSVLGGDC LLKFSLDVCE
     AMEYLEGNNF VHRDLAARNV LVSEDNVAKV SDFGLTKEAS STQDTGKLPV KWTAPEALRE
     KKFSTKSDVW SFGILLWEIY SFGRVPYPRI PLKDVVPRVE KGYKMDAPDG CPPAVYEVMK
     NCWHLDAAMR PSFLQLREQL EHIKTHELHL
//
